Latest Announcements

Procter & Gamble Hygiene and Health Care Limited has informed the Exchange regarding 'SEBI Circular on Ease Of Doing Business - Special Window For Transfer And Dematerialization Of Physical Securities'. Shareholders can lodge transfer requests for cases rejected/returned/not attended to due to deficiency in documents/process/or otherwise till February 4, 2027.

UltraTech Cement Limited has informed the Exchange about a material price movement (MPM) in its share price on 18th September, 2026, which appears to be purely market driven and not triggered by any event or information in the mainstream media.

Bharti Airtel Limited has received an order from Telecom Regulatory Authority of India (TRAI) imposing a financial disincentive of INR 1,10,000/- for alleged non-compliance of the Standards of Quality of Service of Access (Wireline and Wireless) and Broadband (Wireline and Wireless) Service Regulations, 2024 for the month of November 2025.

PI Industries Limited has informed the Exchange about a scheduled meet with UTI Mutual Fund, as per Regulation 30(6) of SEBI (LODR) Regulations, 2015. The meeting will take place on September 23, 2026, at the company's registered office in Udoisogor Rood, Udoipur.

AstraZeneca Pharma India Limited has received a penalty order from the Registrar of Companies (ROC) for a delay in filing Form MR-2 related to the appointment of Dr. Sanjeev Kumar Panchal as Managing Director in 2023. The penalty is Rs. 1,88,000/- on the Company and Rs. 50,000/- each on the erstwhile concerned officers.

Panache Digilife Limited has informed the Exchange about the withdrawal of its credit rating by Infomerics Valuation and Rating Ltd at the company's request, citing a No-Objection Certificate from the bank.

Vikran Engineering Limited has received a Show Cause Notice (SCN) from the Office of the Assistant Commissioner, C.G.S.T. & Central Excise Division – III, Indore, regarding excess ITC availed pertaining to the FY 2022-2023, with a tax demand of Rs. 1,71,20,276 and penalty of Rs. 17,12,027.599.

The Exchange has sought clarification from Nestle India Limited regarding a news item about FSSAI initiating legal action against the company on baby formula, leading to a 2% fall in shares.

India Pesticides Limited has received regulatory approvals for its insecticide and herbicide products in international markets, specifically in the United Kingdom and Argentina.

Anuh Pharma Limited has informed the Exchange about orders passed regarding receipt of Demand Order under Section 156 of the Income Tax Act, 1961. The company has received a Notice of Demand Order for an amount of Rs. 9,93,206/- on account of disallowances and deductions claimed. The company is in process of filing an appeal before the CIT against the said order.

La Opala RG Limited has informed the Exchange regarding 'Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011'.

Kaveri Seed Company Limited has received a notice of hearing from the Income Tax Appellate Tribunal, Hyderabad Benches, regarding an appeal filed by the Income Tax Department against the order passed by the Hon'ble Commissioner of Income Tax (Appeals) for the Assessment Year 2022-23. The matter is scheduled for hearing on 15th October 2026.

KNR Constructions Limited has received an order from the Office of Commissioner of Income Tax – Appeals, Hyderabad-12, deleting a penalty of Rs. 18,22,08,922/- for the AY 2007-08.

Ponni Sugars (Erode) Limited has informed the Exchange about a special one-year window for transfer and dematerialization of physical securities sold/purchased prior to April 01, 2019.

SJVN Limited has received notices from BSE and NSE imposing fines for non-compliance with certain provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has sent requests to the Ministry of Power and MPP and Power to expedite the appointment of Independent Directors on the Board to comply with the requirements.

HALEOS LABS LIMITED has informed about the successful USFDA inspection of its material subsidiary, Mahi Drugs Private Limited, with zero Form 483 observations, reflecting the company's commitment to regulatory compliance and quality.

Astec LifeSciences Limited has responded to a notice from the National Stock Exchange regarding a significant increase in volume, confirming compliance with listing regulations and stating that there are no developments requiring mandatory disclosure.

Concord Biotech Limited has announced that the USFDA has successfully completed an inspection at its Valthera Formulation Facility with one minor procedural observation unrelated to GMP. The company will submit a comprehensive response within the stipulated timeline.

Dr. Reddy's Laboratories Limited has clarified a news article regarding a voluntary license for Gilead's once-yearly HIV prevention drug, stating that the news is correct and the company has made a press release on the matter.

Manipal Payment and Identity Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The company's trading window will remain closed from September 18, 2026, and will reopen after 48 hours from the announcement of the financial results for the quarter ended June 30, 2026, and September 30, 2026.